Long term treatment with (−)deprenyl reduces the optimal dose as well as the effective dose range for increasing antioxidant enzyme activities in old mouse brain
- 1 August 1996
- journal article
- Published by Elsevier in Life Sciences
- Vol. 59 (13) , 1047-1057
- https://doi.org/10.1016/0024-3205(96)00420-1
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- (-)deprenyl increases activities of Superoxide Dismutase (SOD) in striatum of dog brainLife Sciences, 1994
- (-)Deprenyl increases activities of superoxide dismutase and catalase in certain brain regions in old male miceLife Sciences, 1994
- Chronic treatment of (-)deprenyl prolongs the life span of male fischer 344 rats. Further evidenceLife Sciences, 1993
- Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1993
- (−)Deprenyl increases activities of superoxide dismutase and catalase in striatum but not in hippocampus: The sex and age-related differences in the optimal dose in the ratExperimental Neurology, 1992
- (−) deprenyl induces activities of both superoxide dismutase and catalase but not of glutathione peroxidase in the striatum of young male ratsLife Sciences, 1991
- Maintenance on l-deprenyl prolongs life in aged male ratsLife Sciences, 1990
- Effect of Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1989
- The Effect of Deprenyl (Selegiline) on the Natural History of Parkinson's DiseaseScience, 1989
- The striatal dopamine dependency of life span in male rats. Longevity study with (−)deprenylMechanisms of Ageing and Development, 1988